Serum Concentrations of TNF α and Its Soluble Receptors in Patients with Adrenal Tumors Treated by Surgery

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2010 Jul 20

PMID 20640152

Citations 1

Authors

Jan Komorowski

Jolanta Jurczynska

Tomasz Stepien

Krzysztof Kolomecki

Krzysztof Kuzdak

Henryk Stepien

Affiliations

Soon will be listed here.

Abstract

The peripheral blood levels of TNF alpha and its soluble receptors were studied in 39 patients with malignant and benign adrenal tumors treated by adrenalectomy. The concentrations of TNF alpha were significantly elevated in patients with malignant tumors of the adrenal cortex and in patients with Conn's syndrome compared to control. In patients with non-functioning adenomas and pheochromocytomas, TNF alpha levels were similar to those detected in the control. In subjects with myelolipomas, the serum concentration of TNF alpha was lower compared to the control. After adrenalectomy, the levels of TNF alpha were decreased in patients with malignant tumors and in patients with Conn's syndrome, nonfunctioniong adenomas and pheochromocytomas compared to the concentration before surgery. The serum concentrations of soluble receptors of TNF alpha did not differ among different patient groups and compared to the control. After adrenalectomy, the blood concentrations of TNF alpha R1 and TNF alpha R2 were decreased in patients with Conn's syndrome. However, to confirm practicality of the evaluation of TNF alpha and its soluble receptors in differential diagnosis in patients with adrenal tumors, a larger study group is needed.

Citing Articles

Apoptosis regulation in adrenocortical carcinoma.

Pereira S, Monteiro M, Antonini S, Pignatelli D Endocr Connect. 2019; 8(5):R91-R104.

PMID: 30978697 PMC: 6510712. DOI: 10.1530/EC-19-0114.

References

Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D . Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992; 175(2):323-9. PMC: 2119112. DOI: 10.1084/jem.175.2.323. View

Amadori S, Cava M, De Sanctis V, Petti M, Di Gregorio A, Sgadari C . Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients. Leukemia. 1991; 5(1):32-5. View

MacEwan D . TNF ligands and receptors--a matter of life and death. Br J Pharmacol. 2002; 135(4):855-75. PMC: 1573213. DOI: 10.1038/sj.bjp.0704549. View

Leibovich S, Polverini P, Shepard H, Wiseman D, Shively V, Nuseir N . Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987; 329(6140):630-2. DOI: 10.1038/329630a0. View

Vila-Del Sol V, Punzon C, Fresno M . IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol. 2008; 181(7):4461-70. DOI: 10.4049/jimmunol.181.7.4461. View

Guardiola-Serrano F, Haendeler J, Lukosz M, Sturm K, von Melchner H, Altschmied J . Gene trapping identifies a putative tumor suppressor and a new inducer of cell migration. Biochem Biophys Res Commun. 2008; 376(4):748-52. DOI: 10.1016/j.bbrc.2008.09.070. View

Path G, Bornstein S, Spath-Schwalbe E, Scherbaum W . Direct effects of interleukin-6 on human adrenal cells. Endocr Res. 1996; 22(4):867-73. DOI: 10.1080/07435809609043788. View

Hieber U, Heim M . Tumor necrosis factor for the treatment of malignancies. Oncology. 1994; 51(2):142-53. DOI: 10.1159/000227329. View

Kwon B, Youn B, Kwon B . Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol. 1999; 11(3):340-5. DOI: 10.1016/s0952-7915(99)80054-5. View

10.

Andus T, Gross V, Holstege A, Ott M, Weber M, David M . High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology. 1992; 16(3):749-55. DOI: 10.1002/hep.1840160322. View

11.

Call G, Husein O, McIlmoil C, Adams A, Heckmann R, Judd A . Bovine adrenal cells secrete interleukin-6 and tumor necrosis factor in vitro. Gen Comp Endocrinol. 2000; 118(2):249-61. DOI: 10.1006/gcen.2000.7458. View

12.

Wilder R . Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol. 1995; 13:307-38. DOI: 10.1146/annurev.iy.13.040195.001515. View

13.

Gonzalez-Hernandez J, Ehrhart-Bornstein M, Spath-Schwalbe E, Scherbaum W, Bornstein S . Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid: evidence for paracrine control of adrenal function. J Clin Endocrinol Metab. 1996; 81(2):807-13. DOI: 10.1210/jcem.81.2.8636308. View

14.

Jurczynska J, Zieleniewski W, Stepien H, Komorowski J . Angiogenic and anti-angiogenic factors in adrenal tumours. Endokrynol Pol. 2007; 57(6):633-40. View

15.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E . Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma. 2009; 56(1):56-62. DOI: 10.4149/neo_2009_01_56. View

16.

Smith C, Davis T, Anderson D, Solam L, Beckmann M, Jerzy R . A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 1990; 248(4958):1019-23. DOI: 10.1126/science.2160731. View

17.

Jurczynska J, Stepien T, Lawnicka H, Stepien H, Krupinski R, Kolomecki K . Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery. Endokrynol Pol. 2009; 60(1):9-13. View

18.

Wellmer A, Gerber J, Ragheb J, Zysk G, Kunst T, Smirnov A . Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun. 2001; 69(11):6881-6. PMC: 100067. DOI: 10.1128/IAI.69.11.6881-6886.2001. View

19.

Pasparakis M, Alexopoulou L, Episkopou V, Kollias G . Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune.... J Exp Med. 1996; 184(4):1397-411. PMC: 2192824. DOI: 10.1084/jem.184.4.1397. View

20.

Austgulen R, Liabakk N, Brockhaus M, Espevik T . Soluble TNF receptors in amniotic fluid and in urine from pregnant women. J Reprod Immunol. 1992; 22(2):105-16. DOI: 10.1016/0165-0378(92)90009-s. View